Medeon Biodesign Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	351.87	520.79	513.37	1,238	483.9	735.32
Short-Term Investments	410.82	656.96	652.18	862.1	1,025	1,608
Trading Asset Securities	38.02	42.12	41.66	41.93	37.87	6.48
Cash & Short-Term Investments	800.71	1,220	1,207	2,142	1,547	2,350
Cash Growth	-14.58%	1.05%	-43.64%	38.44%	-34.16%	7.49%
Accounts Receivable	252.33	39.26	37.84	41.77	32.35	10.12
Other Receivables	10.42	7.17	7.71	8.37	26.65	5.12
Receivables	262.75	46.43	45.55	50.15	59.01	15.25
Inventory	27.16	24.84	34.1	10.77	10.06	-
Prepaid Expenses	31.12	-	-	24.89	21.42	24.68
Other Current Assets	-	31.02	30.34	-	-	-
Total Current Assets	1,122	1,322	1,317	2,228	1,638	2,390
Property, Plant & Equipment	270.27	267.83	355.47	321.82	340.24	44.52
Long-Term Investments	-	-	-	-	1,876	1,847
Goodwill	-	106.74	106.74	106.74	106.74	39.23
Other Intangible Assets	144.77	45.36	55.01	64.33	73.44	39.71
Long-Term Deferred Tax Assets	32.95	32.95	32.95	-	-	-
Other Long-Term Assets	9.1	4.77	10.37	26.46	5.59	4.58
Total Assets	1,579	1,780	1,878	2,747	4,040	4,364

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	7.99	7.55	12	5.36	3.94	0.05
Accrued Expenses	-	85.37	113.03	98.01	73.09	68.33
Current Portion of Leases	36.99	41.39	54.56	47.15	36.69	14.53
Current Income Taxes Payable	-	-	-	37.97	56.78	66.74
Current Unearned Revenue	3.46	7.94	4.51	3.11	0.86	0.65
Other Current Liabilities	81.73	18.7	31.54	30.16	27.17	10
Total Current Liabilities	130.16	160.96	215.64	221.76	198.51	160.3
Long-Term Leases	105.72	71.66	113.84	139.59	162.22	15.71
Long-Term Deferred Tax Liabilities	8.95	10.41	12.36	14.31	15.74	-
Total Liabilities	244.83	243.03	341.84	375.65	376.48	176

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	969.45	969.45	922.45	922.45	878.4	732.34
Additional Paid-In Capital	1,722	-	-	1,341	1,344	1,349
Retained Earnings	-1,666	-1,496	-792.94	31.25	1,355	2,072
Treasury Stock	-	-	-5.25	-10.6	-10.6	-10.6
Comprehensive Income & Other	281.76	2,002	1,396	36.18	30.94	-12.49
Total Common Equity	1,308	1,476	1,520	2,320	3,597	4,130
Minority Interest	26.42	61.03	15.71	51.51	66.1	58.15
Shareholders' Equity	1,334	1,537	1,536	2,371	3,664	4,188
Total Liabilities & Equity	1,579	1,780	1,878	2,747	4,040	4,364

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	142.7	113.05	168.4	186.74	198.91	30.24
Net Cash (Debt)	658.01	1,107	1,039	1,955	1,348	2,320
Net Cash Growth	-19.00%	6.55%	-46.87%	45.01%	-41.87%	36.98%
Net Cash Per Share	6.86	11.99	11.27	21.24	14.65	25.19
Filing Date Shares Outstanding	97.47	96.94	92.14	92.04	92.02	92.02
Total Common Shares Outstanding	97.47	96.94	92.14	92.04	92.02	92.02
Working Capital	991.57	1,161	1,102	2,006	1,439	2,230
Book Value Per Share	13.41	15.22	16.50	25.21	39.10	44.89
Tangible Book Value	1,163	1,324	1,358	2,149	3,417	4,051
Tangible Book Value Per Share	11.93	13.65	14.74	23.35	37.14	44.03
Machinery	-	220.85	229.55	178.49	168.97	46.34
Leasehold Improvements	-	100.5	84.96	46.22	45.6	6.43